Metabolic Disease and The Risk of Post-COVID Conditions: A Retrospective Cohort Study.
Wubin XieHeather E HsuPaul R ShaferMeghan I PodolskyAndrew C StokesPublished in: medRxiv : the preprint server for health sciences (2024)
In a large national cohort of commercially insured adults, COVID-19 patients with a baseline metabolic condition had the highest risk of developing new clinical sequelae post-acute infection phase, followed by those who had baseline metabolic condition but no COVID-19 infection and those who had COVID-19 but no baseline metabolic disorder.